Jacksonville, FL7 Active Studies

Chronic Lymphocytic Leukemia Clinical Trials in Jacksonville, FL

Find 7 actively recruiting chronic lymphocytic leukemia clinical trials in Jacksonville, FL. Connect with local research sites and explore new treatment options.

7
Active Trials
6
Sponsors
1,734
Enrolling

Recruiting Chronic Lymphocytic Leukemia Studies in Jacksonville

About Chronic Lymphocytic Leukemia Clinical Trials in Jacksonville

Chronic lymphocytic leukemia (CLL) is a slow-growing cancer of the blood and bone marrow that affects B lymphocytes. It is the most common type of adult leukemia. Treatment options include targeted therapies, chemotherapy, and immunotherapy.

There are currently 7 chronic lymphocytic leukemia clinical trials recruiting participants in Jacksonville, FL. These studies are seeking a combined 1,734 participants. Research is being sponsored by BeOne Medicines, Ascentage Pharma Group Inc., BeiGene and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Chronic Lymphocytic Leukemia Clinical Trials in Jacksonville — FAQ

Are there chronic lymphocytic leukemia clinical trials in Jacksonville?

Yes, there are 7 chronic lymphocytic leukemia clinical trials currently recruiting in Jacksonville, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Jacksonville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Jacksonville research site will contact you about next steps.

Are clinical trials in Jacksonville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Jacksonville studies also compensate for your time and travel.

What chronic lymphocytic leukemia treatments are being tested?

The 7 active trials in Jacksonville are testing new therapies including novel drugs, biologics, and treatment approaches for chronic lymphocytic leukemia.

Data updated October 18, 2026 from ClinicalTrials.gov